- Investing Ideas
- /
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Dentium
Market Cap: ₩502.8b
Manufactures and sells dental medical instrument worldwide.
A145720
₩58,300.00
7D
2.3%
1Y
-7.2%
T&L
Market Cap: ₩356.8b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩44,200.00
7D
-3.9%
1Y
-34.8%
InBodyLtd
Market Cap: ₩332.8b
Provides body composition analysis solutions worldwide.
A041830
₩27,300.00
7D
-4.7%
1Y
12.8%
Suheung
Market Cap: ₩301.3b
Engages in produces and sells hard and soft capsules.
A008490
₩27,100.00
7D
1.3%
1Y
75.4%
Meta Biomed
Market Cap: ₩164.9b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩6,120.00
7D
8.9%
1Y
51.1%
Vieworks
Market Cap: ₩162.1b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩18,070.00
7D
-4.5%
1Y
-22.8%
OSTEONIC
Market Cap: ₩136.4b
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems.
A226400
₩6,800.00
7D
-5.6%
1Y
11.3%